Terms: = Cervical cancer AND MALAT1, PRO1073, 378938, Q9UHZ2
36 results:
1. Knockdown of lncRNA
Liang T; Lu T; Jia W; Li R; Jiang M; Jiao Y; Wang Y; Cong S; Jiang X; Dong L; Zhou Y; Zhang G; Xiao D
Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37921054
[TBL] [Abstract] [Full Text] [Related]
2. The HPV-TP53-malat1 Axis: Unravelling interactions in cervical cancer development.
Iordanishvili S; Metreveli T; Lipartia E; Gachechiladze K; Khuntsaria I; Qobulashvili T; Jorbenadze M; Revazishvili T; Kldiashvili E; Kaufmann AM
PLoS One; 2023; 18(10):e0291725. PubMed ID: 37812599
[TBL] [Abstract] [Full Text] [Related]
3. The involvement of malat1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer.
Wu S; Liu L; Xu H; Zhu Q; Tan M
Cancer Biol Ther; 2023 Dec; 24(1):2249174. PubMed ID: 37639643
[TBL] [Abstract] [Full Text] [Related]
4. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract] [Full Text] [Related]
5. Alteration of Gene and miRNA Expression in cervical Intraepithelial Neoplasia and cervical cancer.
Dudea-Simon M; Mihu D; Pop LA; Ciortea R; Malutan AM; Diculescu D; Ciocan CA; Cojocneanu RM; Simon V; Bucuri C; Mocan-Hognogi R; Braicu C; Berindan-Neagoe I
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682732
[No Abstract] [Full Text] [Related]
6.
Tie W; Ge F
DNA Cell Biol; 2021 Nov; 40(11):1407-1417. PubMed ID: 34610246
[TBL] [Abstract] [Full Text] [Related]
7. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin.
Taheri M; Shoorei H; Tondro Anamag F; Ghafouri-Fard S; Dinger ME
Exp Mol Pathol; 2021 Dec; 123():104602. PubMed ID: 33422487
[TBL] [Abstract] [Full Text] [Related]
8. Roles and Mechanisms of the Long Noncoding RNAs in cervical cancer.
Cáceres-Durán MÁ; Ribeiro-Dos-Santos Â; Vidal AF
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371204
[TBL] [Abstract] [Full Text] [Related]
9. Exercise-mediated downregulation of malat1 expression and implications in primary and secondary cancer prevention.
Paronetto MP; Dimauro I; Grazioli E; Palombo R; Guidotti F; Fantini C; Sgrò P; De Francesco D; Di Luigi L; Capranica L; Caporossi D
Free Radic Biol Med; 2020 Nov; 160():28-39. PubMed ID: 32768573
[TBL] [Abstract] [Full Text] [Related]
10. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.
Xia C; Liu C; He Z; Cai Y; Chen J
J Exp Clin Cancer Res; 2020 Jul; 39(1):127. PubMed ID: 32631421
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA-625-5p Sponges lncRNA malat1 to Inhibit cervical Carcinoma Cell Growth by Suppressing NF-κB Signaling.
Li Y; Ding Y; Ding N; Zhang H; Lu M; Cui X; Yu X
Cell Biochem Biophys; 2020 Jun; 78(2):217-225. PubMed ID: 32152961
[TBL] [Abstract] [Full Text] [Related]
12. IL-6/STAT3 mediates the HPV18 E6/E7 stimulated upregulation of malat1 gene in cervical cancer HeLa cells.
Hao Y; Yan Z; Zhang A; Hu S; Wang N; Luo XG; Ma W; Zhang TC; He H
Virus Res; 2020 May; 281():197907. PubMed ID: 32113834
[TBL] [Abstract] [Full Text] [Related]
13. iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin.
Xia C; Yang F; He Z; Cai Y
Biomed Pharmacother; 2020 Mar; 123():109762. PubMed ID: 31864213
[TBL] [Abstract] [Full Text] [Related]
14. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W
J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360
[TBL] [Abstract] [Full Text] [Related]
15. malat1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.
Wang N; Hou MS; Zhan Y; Shen XB; Xue HY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7653-7659. PubMed ID: 30536307
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of malat1 contributes to cervical cancer progression by acting as a sponge of miR-429.
Shen F; Zheng H; Zhou L; Li W; Xu X
J Cell Physiol; 2019 Jul; 234(7):11219-11226. PubMed ID: 30515786
[TBL] [Abstract] [Full Text] [Related]
17. Long non-coding RNAs and cervical cancer.
Aalijahan H; Ghorbian S
Exp Mol Pathol; 2019 Feb; 106():7-16. PubMed ID: 30471246
[TBL] [Abstract] [Full Text] [Related]
18. Association Between malat1 and THRIL Polymorphisms and Precancerous cervical Lesions.
Wang Y; Liu Y; Li Z; Yan X; Huang C; Ye X; Sun X; Qin S; Zhong X; Zeng C; Liu D; Zou X; Liu Y; Wu J; Wen Z; Yang G; Jing C; Wei X
Genet Test Mol Biomarkers; 2018 Sep; 22(9):509-517. PubMed ID: 30188187
[TBL] [Abstract] [Full Text] [Related]
19. Correlation study between long non-coding RNA malat1 and radiotherapy efficiency on cervical carcinoma and generation of radiotherapy resistant model of cancer.
Zhu P; Wang FQ; Li QR
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5140-5148. PubMed ID: 30178834
[TBL] [Abstract] [Full Text] [Related]
20. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the malat1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells.
Xia C; Liang S; He Z; Zhu X; Chen R; Chen J
Eur J Pharmacol; 2018 Jul; 830():59-67. PubMed ID: 29704494
[TBL] [Abstract] [Full Text] [Related]
[Next]
